APA (7th ed.) Citation

PS, K., K, Z., SA, D., S, B., DR, G., AT, S., . . . AV, P. (2025). Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: A double-blind, non-inferiority, randomised, controlled, phase 3 trial. The Lancet. Infectious diseases, 25(10), 1128. https://doi.org/10.1016/S1473-3099(25)00215-4

Chicago Style (17th ed.) Citation

PS, Kulkarni, et al. "Safety and Immunogenicity of a Reduced-dose Inactivated Poliovirus Vaccine Versus a Full-dose Inactivated Poliovirus Vaccine in Infants in Bangladesh: A Double-blind, Non-inferiority, Randomised, Controlled, Phase 3 Trial." The Lancet. Infectious Diseases 25, no. 10 (2025): 1128. https://doi.org/10.1016/S1473-3099(25)00215-4.

MLA (9th ed.) Citation

PS, Kulkarni, et al. "Safety and Immunogenicity of a Reduced-dose Inactivated Poliovirus Vaccine Versus a Full-dose Inactivated Poliovirus Vaccine in Infants in Bangladesh: A Double-blind, Non-inferiority, Randomised, Controlled, Phase 3 Trial." The Lancet. Infectious Diseases, vol. 25, no. 10, 2025, p. 1128, https://doi.org/10.1016/S1473-3099(25)00215-4.